Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.
Kasper RecourtPeter de BoerRob G J A ZuikerRemy LuthringerJustine KentPeter van der ArkIlse Van HoveJoop van GervenGabriel JacobsLuc van NuetenWayne DrevetsPublished in: Translational psychiatry (2019)
In the original Article, Tables two and three had formatting issues which affected their clarity. This has been corrected in the PDF and HTML versions of this Article.